Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for firms to develop new products in the future. While existing research demonstrates [...]
Standard-essential patents (SEPs) have become a key element of technical coordination in standard-setting organizations. Yet, in many cases, it remains unclear whether a declared SEP is truly standard-essential. To date, [...]
With schools closed through the rest of the academic year and reopening in September up in the air for most districts across the U.S., the home has become the classroom. [...]
Poor coordination on the part of the federal government in addressing the COVID-19 pandemic, combined with a lack of preparedness, has led to some very strange cases of the federal [...]
In 2004, Canada changed the eligibility rules for its Scientific Research and Experimental Development (SRED) tax credit, which provides tax incentives for R&D conducted by small private firms. Difference-in-difference estimates [...]
Over the past month, we have seen considerable outrage and excitement over the Internet Archive’s National Emergency Library, an online source of 1.4 million books that are free to borrow [...]
Rent Check Brett Stephens has written a glowing profile of Gilead in which he critiques big Pharma's critics, but these uncritical defenses ignore the very real criticisms against the pharmaceutical [...]
In his New York Times column, Bret Stephens wrote about the promise of the antiviral drug remdesivir as a treatment for COVID-19. The column mostly focuses the efforts of scientists [...]
Rent Check Richard Epstein's models on the spread of COVID-19 have been proven wrong, but his reluctance to abandon the assumptions that inform his model is similar to problems in [...]
Ten years ago, donors committed $1.5 billion to a pilot Advance Market Commitment (AMC) to help purchase pneumococcal vaccine for low-income countries. The AMC aimed to encourage the development of [...]